5 unknown, 2 completed. 1 Early Phase 1, 1 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Premier Specialists, Australia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of the Responsiveness of Investigator Global Assessment Score for Keratosis Pilaris Cutera laser machine - Keratosis Pilaris | Not applicable | Unknown | Premier Specialists, Australia | 15 | 2023-07-26 | 2023-09-11 |
| Validation of 5-Point Investigator Global Assessments for Pemphigus Investigator Global Assessments (IGAs) - Pemphigus | Unknown | Premier Specialists, Australia | 40 | 2022-09-21 | 2022-09-19 | |
| Development and Validation of an Investigator Global Assessment Score for Keratosis Pilaris CeraVe SA Smoothing Cleanser, CeraVe SA Smoothing Cream, Propaira 20% Lactic Acid Exfoliating Lotion - Keratosis Pilaris | Unknown | Premier Specialists, Australia | 15 | 2022-08-13 | 2022-09-10 | |
| Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo Tildrakizumab - Skin and Connective Tissue Diseases, Skin Diseases | Early Phase 1 | Completed | Premier Specialists, Australia | 12 | 2021-09-16 | 2024-11-12 |
| Investigating the Morbidity of Glucocorticoid Use in Patients With Autoimmune Bullous Diseases (AIBDs) GlucoCorticoid - Autoimmune Bullous Dermatosis, Glucocorticoids Toxicity | Unknown | Premier Specialists, Australia | 138 | 2019-02-02 | 2023-08-31 | |
| Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study Sirolimus 2%, Vehicle - Epidermolysis Bullosa Simplex, Epidermolysis Bullosa Simplex Kobner | Phase 2 | Unknown | Premier Specialists, Australia | 8 | 2016-05-01 | 2017-10-24 |
| Study of Two Dosages of Roaccutane in Cystic Acne isotretinoin (Roaccutane) - Acne Cystic | Phase 4 | Completed | Premier Specialists, Australia | 91 | 2001-06-26 | 2025-12-23 |
Burnett Schwartz Berberian syndrome (2) · Epidermolysis Bullosa Simplex (1) · Hypopigmentation (1) · Pemphigus (1) · Pigmentation Disorders (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1) · Vitiligo (1)
Glucocorticoids (1) · Isotretinoin (1) · tildrakizumab (1)
Australia (6) · Bulgaria (1) · Greece (1) · Iran (1) · Israel (1) · Singapore (1) · Turkey (Türkiye) (1)
Dedee F Murrell, MD (1) · Dedee Murrell, MBBS (1) · Dedee Murrell, MD (1)